Celaid Therapeutics
About:
Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Website: https://celaidtx.com
Top Investors: UTEC - The University of Tokyo Edge Capital Partners, Osaka University Venture Capital, Joyo Capital Partners, Tsukuba Institute of Research, Techno Science
Description:
Celaid Therapeutics specializes in manufacturing and sales of regenerative medicine products utilizing human hematopoietic stem cells.
Total Funding Amount:
460M JPY
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Hongo, Tokyo, Japan
Founded Date:
2020-10-08
Contact Email:
contact(AT)celaidtx.com
Founders:
Motoo Watanabe, Nobuyuki Arakawa
Number of Employees:
1-10
Last Funding Date:
2024-05-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai